Focus: Healx is an AI-driven drug discovery company focused on rare diseases and neurology, leveraging artificial intelligence to identify novel therapeutic candidates. The company is a public-stage biotech with headquarters in Cambridge, UK, operating since 2005.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Best suited for technologists and AI specialists willing to bet on rare disease upside; less attractive for commercial or clinical roles given tight headcount.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Healx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Healx's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Healx AI: 10 Essential Facts About the Cambridge Rare Disease Drug Discovery Pioneer - International Business Times Australia
Healx AI: 10 Essential Facts About the Cambridge Rare Disease Drug Discovery Pioneer International Business Times Australia
Artificial Intelligence Biotechnology Market Next Big Thing | Major Giants Healx, Cyclica, Iktos - openPR.com
Artificial Intelligence Biotechnology Market Next Big Thing | Major Giants Healx, Cyclica, Iktos openPR.com
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo